During 2017, Robin Wright Tool Company purchased a building site for its proposed research and development laboratory at a cost of $60,000. Construction of the building was started in 2017. The building was completed on December 31, 2018, at a cost of $320,000 and was placed in service on January 2, 2019. The estimated useful life of the building for depreciation purposes was 20 years. The straight-line method of depreciation was to be employed, and there was no estimated residual value.
Management estimates that about 50% of the projects of the research and development group will result in long-term benefits (i.e., at least 10 years) to the company. The remaining projects either benefit the current period or are abandoned before completion. A summary of the number of projects and the direct costs incurred in conjunction with the research and development activities for 2019 appears below.

Upon recommendation of the research and development group, Robin Wright Tool Company acquired a patent for manufacturing rights at a cost of $88,000. The patent was acquired on April 1, 2018, and has an economic life of 10 years.
Instructions
Under IFRS, how would the items above relating to research and development activities be reported on the following financial statements?
a. The company's income statement for 2019.
b. The company's statement of financial position as of December 31, 2019.
Be sure to give account titles and amounts, and briefly justify your presentation.

Salaries and Other Expenses (Excluding Building Depreciation Number of Projects Employee Benefits $ 90,000 Charges) Completed projects with long-term benefits (cost shown are development costs incurred after achieving economic viability) Abandoned projects or projects that benefit the current period Projects in process-results indeterminate $50,000 15 15,000 10 65,000 40,000 12,000 Total $195,000 $77,000 30